MANA Advisors’s Boston Scientific BSX Stock Holding History

MANA Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-127,226	Closed	-$3.15M	–	213
2017 Q4	$3.15M	Buy	+127,226	New	+$3.51M	1.35%	1

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

MANA Advisors's BSX Position: Q1 2018 in Review

MANA Advisors sold out of Boston Scientific (BSX) in Q1 2018, closing a stake of 127,226 shares — an estimated $3.15M sold.

MANA Advisors first reported a position in BSX in Q4 2017 and held it in 1 quarter. The position peaked at $3.15M in Q4 2017. 633 funds tracked by Wall St. Rank hold BSX as of Q1 2018.

MANA Advisors reported no remaining Boston Scientific position as of Q1 2018 after selling out during the quarter.
MANA Advisors sold 127,226 Boston Scientific shares in Q1 2018, an estimated $3.15M.
MANA Advisors first reported a position in Boston Scientific in Q4 2017 and held it in 1 quarter.
MANA Advisors's Boston Scientific position peaked at $3.15M in Q4 2017.
633 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2018.

Based on MANA Advisors's 13F filing for Q1 2018, filed 15 May 2018.